BCM Oncology Scholars Training Program

描述(由申请者提供)：肿瘤学的翻译研究培训需要一个由多个学科的组成部分组成的指导计划。近年来，具有临床和实验室研究专长的年轻研究人员一直短缺。为了增加翻译癌症研究中有才华的内科科学家和博士科学家的数量，我们需要改善培训机会。BCM肿瘤学学者培训计划旨在满足医学博士(或医学博士/博士)的需求。以及博士生。该计划由五个科学研究主题组成，包括：(1)“全基因组学”科学(基因组学、蛋白质组学和代谢组学)；(2)癌症信号通路；(3)干细胞与发展；(4)治疗和诊断学；(5)癌症流行病学和预防。我们将从贝勒血液学/肿瘤学研究员的每个班级中挑选一名学者，并提供为期三年的研究支持和指导，从奖学金的后半部分开始，一直延伸到初级教员职位的前18个月。为了培养肿瘤学方面的转化型博士，我们还将通过公开竞争的方式，每年从BCM博士后人才库中挑选一名博士后学者，并支持她/他的转化型癌症研究三年。每位学者实习生将接受肿瘤学研究方面的培训计划，包括授课课程、职业发展技能和有指导的实验室研究。每名学员都将获得针对学员具体兴趣的指导。通过研究导师和临床教师之间对医学博士和博士学者的共同指导，以及一系列针对特定项目的研究研讨会，拟议的T32将作为一个平台，为我们的实习生开发转化性癌症合作研究，并促进他们的职业发展。

DESCRIPTION (provided by applicant): Translational research training in oncology requires a mentoring program with components from multiple disciplines. In recent years, there has been a shortage of young investigators with both clinical and laboratory research expertise. In order to increase the pool of talented physician-scientists and Ph.D. scientists in translational cancer research we need to improve training opportunities. The BCM Oncology Scholars Training Program aims to address the needs of both M.D. (or M.D./Ph.D.) and Ph.D. trainees. The program is composed of five scientific research themes including: (1) "Omics" sciences (genomics, proteomics and metabolomics); (2) Cancer signaling pathways; (3) Stem cells and development; (4) Therapeutics and diagnostics; (5) Cancer epidemiology and prevention. From each class of Baylor hematology/oncology fellows, we will select a scholar and provide three years of research support and mentoring, starting in the second half of the fellowship and extending into the first eighteen months of a junior faculty position. To train Ph.D. the translational research in oncology, we will also select a Ph.D. postdoctoral scholar each year from the BCM postdoctoral pool via open competition and support her/his translational cancer research for three years. Each scholar trainee will receive a training program in oncological research including didactic courses, career development skills and mentored laboratory research. Each trainee will receive mentorship tailored to the specific interests of the trainees. Through co-mentorship for the M.D. and Ph.D. scholars between research mentors and clinical faculty, and a program-specific research seminar series, the proposed T32 will serve as a platform to develop translational cancer collaborative research for our trainees and to nurture their career development.